Literature DB >> 15778379

Maintenance of pulmonary Th1 effector function in chronic tuberculosis requires persistent IL-12 production.

Carl G Feng1, Dragana Jankovic, Marika Kullberg, Allen Cheever, Charles A Scanga, Sara Hieny, Patricia Caspar, George S Yap, Alan Sher.   

Abstract

The mechanisms that prevent reactivation of latent Mycobacterium tuberculosis infection in asymptomatic individuals are poorly understood. Although IL-12 is critical for the induction of IFN-gamma-dependent host control of M. tuberculosis, the requirement for the cytokine in the maintenance of host resistance and pulmonary Th1 effector function has not yet been formally examined. In this study, we reconstituted IL-12p40-deficient mice with IL-12 during the first 4 wk of infection and then assessed the effects of cytokine withdrawal. Although IL-12 administration initially resulted in restricted mycobacterial growth and prolonged survival, the reconstituted animals eventually succumbed to infection. This breakdown in bacterial control was accompanied by a marked reduction in the numbers of IFN-gamma-producing CD4(+) T cells in lungs. Moreover, whereas CD4(+) T cells isolated from chronically infected wild-type mice expanded and transferred long-term protection to M. tuberculosis-challenged RAG(-/-) mice, they failed to do so in IL-12p40-deficient RAG(-/-) recipients and were clearly reduced in frequency within pulmonary granulomas in the latter animals. These studies establish that continuous IL-12 production is necessary for maintenance of the pulmonary Th1 cells required for host control of persistent M. tuberculosis infection and suggest that breakdown of this mechanism could be a contributing factor in reactivated disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15778379     DOI: 10.4049/jimmunol.174.7.4185

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  50 in total

1.  The CFP-10/ESAT-6 complex of Mycobacterium tuberculosis potentiates the activation of murine macrophages involvement of IFN-gamma signaling.

Authors:  Si Guo; Lang Bao; Zi Fang Qin; Xin Xin Shi
Journal:  Med Microbiol Immunol       Date:  2010-03-16       Impact factor: 3.402

2.  Enhanced immunogenicity and protective efficacy with the use of interleukin-12-encapsulated microspheres plus AS01B in tuberculosis subunit vaccination.

Authors:  Sang-Jun Ha; Su-Hyung Park; Hye-Ju Kim; Seung-Chul Kim; Hyang-Ju Kang; Eun-Gae Lee; Soon-Geon Kwon; Byong-Moon Kim; Sung-Hee Lee; Won-Bae Kim; Young-Chul Sung; Sang-Nae Cho
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

Review 3.  Interleukin-12 and tuberculosis: an old story revisited.

Authors:  Andrea M Cooper; Alejandra Solache; Shabaana A Khader
Journal:  Curr Opin Immunol       Date:  2007-08-16       Impact factor: 7.486

4.  STIM1 controls T cell-mediated immune regulation and inflammation in chronic infection.

Authors:  Ludovic Desvignes; Carl Weidinger; Patrick Shaw; Martin Vaeth; Theo Ribierre; Menghan Liu; Tawania Fergus; Lina Kozhaya; Lauren McVoy; Derya Unutmaz; Joel D Ernst; Stefan Feske
Journal:  J Clin Invest       Date:  2015-05-04       Impact factor: 14.808

5.  Antigen-activated T cells induce IL-12p75 production from dendritic cells in an IFN-γ-independent manner.

Authors:  K Abdi; N J Singh
Journal:  Scand J Immunol       Date:  2010-12       Impact factor: 3.487

Review 6.  IL-10 production by CD4+ effector T cells: a mechanism for self-regulation.

Authors:  D Jankovic; D G Kugler; A Sher
Journal:  Mucosal Immunol       Date:  2010-03-03       Impact factor: 7.313

Review 7.  IL12Rβ1: the cytokine receptor that we used to know.

Authors:  Richard T Robinson
Journal:  Cytokine       Date:  2014-12-13       Impact factor: 3.861

8.  Disseminated and rapidly fatal tuberculosis in mice bearing a defective allele at IFN regulatory factor 8.

Authors:  Jean-François Marquis; Ronald LaCourse; Lynn Ryan; Robert J North; Philippe Gros
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

9.  Association of reduced tumor necrosis factor alpha, gamma interferon, and interleukin-1beta (IL-1beta) but increased IL-10 expression with improved chest radiography in patients with pulmonary tuberculosis.

Authors:  Wen-Lin Su; Wann-Cherng Perng; Ching-Hui Huang; Cheng-Yu Yang; Chin-Pyng Wu; Jenn-Han Chen
Journal:  Clin Vaccine Immunol       Date:  2009-12-09

10.  Efficacy of Artemisia afra phytotherapy in experimental tuberculosis.

Authors:  Siyabulela Ntutela; Pete Smith; Lungile Matika; James Mukinda; Hiram Arendse; Nasiema Allie; D Mark Estes; Wilfred Mabusela; Peter Folb; Lafras Steyn; Quinton Johnson; William R Folk; James Syce; Muazzam Jacobs
Journal:  Tuberculosis (Edinb)       Date:  2009-12       Impact factor: 3.131

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.